Literature DB >> 28850701

Elevated PT, APPT and PT/INR possibly associated with doxycycline and cefoperazone co-administration: A case report.

X Q Zhu1, C F Guo2, Y G Wen1, D W Shang1, J Q Hu1, S H Deng1, Y Tan2, C Qiu1.   

Abstract

WHAT IS KNOWN AND
OBJECTIVE: Little is known regarding changes in blood coagulation parameters associated with tetracycline antibiotics. We report a possible case of elevated PT, APPT and PT/INR associated with doxycycline and cefoperazone co-administration. CASE
SUMMARY: An 83-year-old Chinese male inpatient with severe pneumonia, chronic renal insufficiency and malnutrition experienced elevated PT, APPT and PT/INR which occurred within a few days of doxycycline added to his cefoperazone treatment and returned to normal after removal of it. WHAT IS NEW AND
CONCLUSION: Very close monitoring of coagulation parameters might be advisable in those subjects when administering doxycycline and cefoperazone concomitantly.
© 2017 John Wiley & Sons Ltd.

Entities:  

Keywords:  case report; cefoperazone; coagulation parameters; doxycycline; drug-drug interaction

Mesh:

Substances:

Year:  2017        PMID: 28850701     DOI: 10.1111/jcpt.12600

Source DB:  PubMed          Journal:  J Clin Pharm Ther        ISSN: 0269-4727            Impact factor:   2.512


  1 in total

1.  Coagulation dysfunction events associated with tigecycline: a real-world study from FDA adverse event reporting system (FAERS) database.

Authors:  Mingxing Guo; Jinwei Liang; Dandan Li; Ying Zhao; Wanyi Xu; Lei Wang; Xiangli Cui
Journal:  Thromb J       Date:  2022-03-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.